Acute liver failure laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:




==Overview==
Overview
All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged by ≈ 4-6 seconds or more (INR ≥1.5) and there is any evidence of altered [[sensorium]], the diagnosis of ALF should be strongly suspected and hospital admission is mandatory.
 
Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease. All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged (INR ≥1.5) and there is any evidence of altered [[sensorium]], the diagnosis of acute liver failure should be strongly suspected and hospital admission is mandatory.


==Laboratory Findings==
==Laboratory Findings==
Line 19: Line 20:
* Increased
* Increased
|
|
* Prolonged prothrombin time, resulting in an INR ≥1.5; it shows coagulopathy which is a part of acute liver failure criteria.  
* Prolonged [[prothrombin time]], resulting in an INR ≥1.5; it shows [[coagulopathy]] which is a part of acute liver failure criteria.  
|-
|-
| align="center" style="background:#DCDCDC;" + |
| align="center" style="background:#DCDCDC;" + |
Line 26: Line 27:
* Low
* Low
|
|
* Anemia may be present  
* [[Anemia]] may be present  
|-
|-
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |
Line 33: Line 34:
* Elevated  
* Elevated  
|
|
* Liver enzymes are elevated in acute liver failure. The decrease in liver enzymes may indicate recovery or worsening of liver failure and an indication of loss of hepatic mass.  
* [[Liver enzymes]] are elevated in acute liver failure. The decrease in liver enzymes may indicate recovery or worsening of liver failure and an indication of hepatic mass loss.  
|-
|-
|
|
Line 40: Line 41:
* Elevated
* Elevated
|
|
* Bilirubin and PT/INR will will continue to rise in liver failure bua patienttient is improving, bilirubin and PT/INT will also improve.
* [[Bilirubin]] and [[INR|PT/INR]] will continue to rise in liver failure but if a patient is improving, bilirubin and PT/INT will also improve.
|-
|-
|
|
Line 47: Line 48:
* Low
* Low
|
|
* Albumin indicates the synthetic function of the liver.
* [[Albumin]] indicates the synthetic function of the liver.
|-
|-
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |
Line 54: Line 55:
* Low  
* Low  
|
|
* Decrease hepatic glycogenolysis and gluconeogenesis   
* Decrease hepatic [[glycogenolysis]] and [[gluconeogenesis]]  
|-
|-
|
|
Line 61: Line 62:
* Elevated
* Elevated
|
|
* Decrease clearance in hepatorenal syndrome
* Decrease clearance in [[hepatorenal syndrome]]
|-
|-
| align="center" style="background:#DCDCDC;" + |
| align="center" style="background:#DCDCDC;" + |
Line 67: Line 68:
|
|
|
|
* Detectable in acetaminophen poisioning
* Detectable in [[acetaminophen]] poisioning
|-
|-
| align="center" style="background:#DCDCDC;" + |
| align="center" style="background:#DCDCDC;" + |
Line 74: Line 75:
* Dectectable in viral hepatitis
* Dectectable in viral hepatitis
|
|
* Viral serology and PCR can detect the viral agent
* Viral serology and [[PCR]] can detect the viral agent
|-
|-
|
|
Line 81: Line 82:
* Detectable in auto immune hepatitis.
* Detectable in auto immune hepatitis.
|
|
* Antibody screen can detect antibodies associated with autoimmune hepatitis such as anti-smooth muscle antibody or ANA.
* Antibody screen can detect antibodies associated with [[autoimmune hepatitis]] such as [[anti-smooth muscle antibody]] or [[ANA]].
|-
|-
|
|
Line 87: Line 88:
|
|
|
|
* Elevated in wilson's disease
* Elevated in [[Wilson's disease|wilson's]] disease
|-
|-
|
|
Line 94: Line 95:
* Elevated
* Elevated
|
|
* Blood lactate is elevated due to decrease hepatic clearance and ischemia to hepatic tissue
* Blood [[lactate]] is elevated due to decrease [[hepatic]] clearance and [[ischemia]] to hepatic tissue
|-
|-
|
|
Line 101: Line 102:
* Elevated
* Elevated
|
|
* Decrease ammonia clearance
* Decrease [[ammonia]] clearance
|}
|}



Revision as of 19:21, 16 November 2017

Acute liver failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Liver Failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute liver failure laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute liver failure laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute liver failure laboratory findings

CDC on Acute liver failure laboratory findings

Acute liver failure laboratory findings in the news

Blogs on Acute liver failure laboratory findings

Directions to Hospitals Treating Acute liver failure

Risk calculators and risk factors for Acute liver failure laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:


Overview

Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease. All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged (INR ≥1.5) and there is any evidence of altered sensorium, the diagnosis of acute liver failure should be strongly suspected and hospital admission is mandatory.

Laboratory Findings

  • Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease.[1]
LAB values in Acute liver failure Comments
  • Increased
  • Low
  • Elevated
  • Liver enzymes are elevated in acute liver failure. The decrease in liver enzymes may indicate recovery or worsening of liver failure and an indication of hepatic mass loss.
  • Elevated
  • Bilirubin and PT/INR will continue to rise in liver failure but if a patient is improving, bilirubin and PT/INT will also improve.
  • Low
  • Albumin indicates the synthetic function of the liver.
  • Low
  • Elevated
  • Dectectable in viral hepatitis
  • Viral serology and PCR can detect the viral agent
  • Detectable in auto immune hepatitis.
  • Elevated
  • Elevated

References

  1. Polson J, Lee WM (2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455.

Template:WH Template:WS